RAMPY NORTHRUP LLC for HARMONY BIOSCIENCES, LLC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; access to non-controlled medications; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5585, Advanced Research Project Agency-Health Act; H.R.6963, Accelerated Approval Integrity Act of 2022; H.R.2623, Camerons Law; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.8641, Orphan Drug COVID-19 Mitigation Act of 2022; H.R.1730/S.670, The Speeding Therapy Access Today (STAT) Act of 2021; H.R.2617, Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN NORTHRUP | — |
| STACEY RAMPY | — |
Taxation/Internal Revenue Code TAX
Issues related to Research and Development Tax Amortization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN NORTHRUP | — |
| STACEY RAMPY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.